Preclinical studies in rodent and canine HF models have shown that GLP-1 RAs improve LVEF, reduce myocardial inflammation and apoptosis, enhance glucose uptake in cardiomyocytes, and improve survival by attenuating oxidative stress and TNF signaling [49,50,51,52,53,54]. This evidence concerns the gene GLP1R and hydrops fetalis.